This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


1tv6

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:1tv6.jpg|left|200px]]
+
{{Seed}}
 +
[[Image:1tv6.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1tv6| PDB=1tv6 | SCENE= }}
{{STRUCTURE_1tv6| PDB=1tv6 | SCENE= }}
-
'''HIV-1 Reverse Transcriptase Complexed with CP-94,707'''
+
===HIV-1 Reverse Transcriptase Complexed with CP-94,707===
-
==Overview==
+
<!--
-
We have determined the crystal structure of the HIV type 1 reverse transcriptase complexed with CP-94,707, a new nonnucleoside reverse transcriptase inhibitor (NNRTI), to 2.8-A resolution. In addition to inhibiting the wild-type enzyme, this compound inhibits mutant enzymes that are resistant to inhibition by nevirapine, efavirenz, and delaviridine. In contrast to other NNRTI complexes where tyrosines 181 and 188 are pointing toward the enzyme active site, the binding pocket in this complex has the tyrosines pointing the opposite direction, as in the unliganded protein structure, to accommodate CP-94,707. This conformation of the pocket has not been observed previously in NNRTI complexes and substantially alters the shape and surface features that are available for interactions with the inhibitor. One ring of CP-94,707 makes extensive stacking interactions with tryptophan 229, one of the few residues in the NNRTI-binding pocket that cannot readily mutate to give rise to drug resistance. In this conformation of the pocket, mutations of tyrosines 181 and 188 are less likely to disrupt inhibitor binding. Modeling the asparagine mutation of lysine 103 shows that a hydrogen bond between it and tyrosine 188 could form as readily in the CP-94,707 complex as it does in the apoenzyme structure, providing an explanation for the activity of this inhibitor against this clinically important mutant.
+
The line below this paragraph, {{ABSTRACT_PUBMED_15249669}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 15249669 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_15249669}}
==About this Structure==
==About this Structure==
Line 27: Line 31:
[[Category: Stirtan, W G.]]
[[Category: Stirtan, W G.]]
[[Category: Transferase]]
[[Category: Transferase]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 10:24:28 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 29 16:05:46 2008''

Revision as of 13:05, 29 July 2008

Image:1tv6.png

Template:STRUCTURE 1tv6

HIV-1 Reverse Transcriptase Complexed with CP-94,707

Template:ABSTRACT PUBMED 15249669

About this Structure

1TV6 is a Protein complex structure of sequences from Human immunodeficiency virus type 1 (isolate bh10). Full crystallographic information is available from OCA.

Reference

Structure of HIV-1 reverse transcriptase bound to an inhibitor active against mutant reverse transcriptases resistant to other nonnucleoside inhibitors., Pata JD, Stirtan WG, Goldstein SW, Steitz TA, Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10548-53. Epub 2004 Jul 12. PMID:15249669

Page seeded by OCA on Tue Jul 29 16:05:46 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/1tv6"
Personal tools